U.S. markets closed
  • S&P 500

    3,901.36
    +0.57 (+0.01%)
     
  • Dow 30

    31,261.90
    +8.77 (+0.03%)
     
  • Nasdaq

    11,354.62
    -33.88 (-0.30%)
     
  • Russell 2000

    1,773.27
    -2.96 (-0.17%)
     
  • Crude Oil

    110.35
    +0.46 (+0.42%)
     
  • Gold

    1,845.10
    +3.90 (+0.21%)
     
  • Silver

    21.76
    -0.14 (-0.65%)
     
  • EUR/USD

    1.0562
    -0.0026 (-0.24%)
     
  • 10-Yr Bond

    2.7870
    -0.0680 (-2.38%)
     
  • GBP/USD

    1.2496
    +0.0021 (+0.17%)
     
  • USD/JPY

    127.8500
    +0.0560 (+0.04%)
     
  • BTC-USD

    29,390.66
    -900.98 (-2.97%)
     
  • CMC Crypto 200

    650.34
    -23.03 (-3.42%)
     
  • FTSE 100

    7,389.98
    +87.24 (+1.19%)
     
  • Nikkei 225

    26,739.03
    +336.19 (+1.27%)
     

Forget Bargains, Play 5 Stocks With Rising P/E Instead

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·5 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Stocks with low P/E are always investors’ favorites as the ratio indicates undervaluation. This ratio is obtained by dividing a stock’s current market price with its historical or estimated earnings. It measures how much an investor needs to shell out per dollar of earnings.

So, the golden rule is – the lower the P/E of a stock, the higher its value for investors. This is because value investors believe that a stock's current market price is not reflective of its historical/future earnings and therefore chances of outperformance are higher.

Naturally, there are very few investors who pay attention to stocks with an increasing P/E. But this often-overlooked trend can prove worthwhile in finding great stocks. Let’s dig a little deeper.

How Can Rising P/E Be Helpful?

Investors should note that stock prices move in tandem with earnings performance. If earnings come in stronger, the price of a stock soars. Solid quarterly earnings and guidance in turn boost the earnings forecast, leading to stronger demand for the stock and an uptrend in its price.

So, if the price is rising steadily, it means that investors are assured of the stock’s fundamental strength, expect some strong positives out of it as well as solid and faster earnings growth. Moreover, studies have revealed that stocks have seen their P/E ratios jump over 100% from their breakout point in the cycle. So, if you can pick stocks early in their breakout cycle, you can end up seeing considerable gains.

The Winning Strategy

In order to shortlist stocks that are exhibiting an increasing P/E, we chose the following as our primary screening parameters.

EPS growth estimate for the current year is greater than or equal to last year’s actual growth.

Percentage change in last year EPS should be greater than or equal to the previous year.

(These two criteria point to flat earnings or a growth trend over the years)

Percentage change in price over four weeks greater than the percentage change in price over 12 weeks.

Percentage change in price over 12 weeks greater than percentage change in price over 24 weeks.

(These two criteria show that the price of the stock is increasing consistently over the said timeframes)

Percentage price change for four weeks relative to the S&P 500 greater than the percentage price change for 12 weeks relative to the S&P 500.

Percentage price change for 12 weeks relative to the S&P 500 greater than the percentage price change for 24 weeks relative to the S&P 500.

(Here, the case for consistent price gains gets even stronger as it displays percentage price changes relative to the S&P 500)

Percentage price change for 12 weeks is 20% higher than or equal to the percentage price change for 24 weeks, but it should not exceed 100%.

(A 20% increase in the price of a stock from the breakout point gives cues of an impending uptrend. But a jump of over 100% indicates that there is limited scope for further upside and that the stock might be due for a reversal)

In addition, we place a few other criteria that lead us to some likely outperformers.

Zacks Rank less than or equal to 2: Only companies with a Strong Buy or Buy rating can get through.

Average 20-day Volume greater than or equal to 50,000: High trading volume implies that the stocks have adequate liquidity.

Just these few criteria narrowed down the universe from over 7,700 stocks to just 49.

Here are the five out of 49 stocks:

SunOpta STKL: SunOpta Inc. is an operator of high-growth ethical businesses, focusing on integrated business models in the natural and organic food, supplements and health and beauty markets.

The average four-quarter earnings surprise of SunOpta is 125%. STKL has a Zacks Rank #1 (Strong Buy).

Sirius XM SIRI: It is a radio broadcasting company creating and broadcasting a variety of content such as commercial-free music, premier sports and live events, news and comedy and exclusive talk and entertainment shows.

The average four-quarter earnings surprise of Sirius XM is 28.46%. SIRI has a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Capricor Therapeutics CAPR: This Zacks Rank #2 company is focused on the development of novel therapeutics to prevent and treat heart disease.

The average four-quarter earnings surprise of CAPR is 15.72%. Capricor Therapeutics has a Zacks Rank #2.

ENDRA Life Sciences NDRA: The Zacks Rank #2 company is a developer of enhanced ultrasound technologies.

The average four-quarter earnings surprise of ENDRA Life Sciences is 10.72%.

The Boston Beer Company SAM: Boston Beer produces beer, malt beverages and cider products at company-owned breweries and under contract. SAM has a Zacks Rank #2.

The average four-quarter earnings surprise of Boston Beer is 4.34%.

The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.

Click here to sign up for a free trial to the Research Wizard today.

Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.

Disclosure: Performance information for Zacks’ portfolios and strategies are available at: https://www.zacks.com/performance


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Sirius XM Holdings Inc. (SIRI) : Free Stock Analysis Report
 
SunOpta, Inc. (STKL) : Free Stock Analysis Report
 
The Boston Beer Company, Inc. (SAM) : Free Stock Analysis Report
 
Capricor Therapeutics, Inc. (CAPR) : Free Stock Analysis Report
 
ENDRA Life Sciences Inc. (NDRA) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.